SHARE THIS PAGE:
This Research/Other Pub section includes peer-reviewed articles on cutting edge research or on existing research to either substantiate it or question its findings. Peer-reviewed articles are those in which a panel of experts in the same fields as the authors reviews the articles prior to publication to ensure scientific quality. This section also includes other publications which are not peer-reviewed.
The LDA is providing the articles in this section for your information. The articles included express the findings and opinions of the authors and are not necessarily those of the the LDA.
The Oxford University Press (McGowan, M. S., et al.) 10.24.2023, published “Acute Lyme Disease With Atypical Features due to Borrelia mayonii.” This article discusses the emergence of a new strain of Lyme disease called Borrelia mayonii and its limited impact since its identification in the US in 2016. Only a few cases have been reported, emphasizing the need for increased awareness.
JAMA Network (Vordenberg, S. E.) published on 11.03.2023 an article, “Topical Nonprescription Pain Medications for Adults.” In this article post, Vordenberg talks about nonprescription pain medications that you can buy without a prescription. These medications are applied directly to the skin to relieve pain.
Topical Nonprescription Pain Medications are pain-relieving drugs that you can buy without a prescription and are applied on the skin, making them easy to use. They work by effectively treating pain from various conditions, both short-term and long-term. Since they are applied on the skin, they are less likely to cause side effects or interact with other medications compared to pills. Pain relief usually starts within a few days of using them.
Courthouse News Service (Langford, C.) 11.16.2023, published “Fifth Circuit rejects Lyme disease patients’ coverage-denial conspiracy claims.” The article discusses the ruling of a legal case where patients with long-term Lyme disease were denied coverage and sued the Infectious Diseases Society of America (IDSA) for their stance on chronic Lyme disease. The patients alleged that the IDSA conspired with health insurers to establish guidelines that limited treatment for Lyme disease […]
Frontiers (Stewart Z., et al.) 10.24.2023, published “Crowd-sourced investigation of a potential relationship between Bartonella-associated cutaneous lesions and neuropsychiatric symptoms.” This article explores the potential relationship between Bartonella bacteria infections and psychiatric symptoms, focusing on how certain skin lesions associated with Bartonella might coincide with neuropsychiatric issues.
The Journal of Immunology (Hastey, C. J., et al.) 11.15.2023 published “Borrelia burgdorferi Infection–Induced Persistent IgM Secretion Controls Bacteremia, but Not Bacterial Dissemination or Tissue Burden.” In this study, researchers investigated the immune response of mice to B. burgdorferi infection. They found that Lyme infection creates a continuous production of IgM antibodies in mice primarily by conventional B cells (not B-1 cells), independent of T-cells function.
The Mary Ann Liebert, Inc. (McClung, K.L., et al.) 11.01.2023, published “Seasonality of Amblyomma americanum (Acari: Ixodidae) Activity and Prevalence of Infection with Tick-Borne Disease Agents in North Central Oklahoma.” This article discusses a study focused on Amblyomma americanum, a common tick in the southern United States, and its transmission of diseases to humans and animals.
Newswire (Tufts University) 10.27.2023, published “Powassan Virus: What to Know about this Rare Tick-Borne Disease.” This article discusses the rising cases of Powassan virus, a tick-borne infection with no vaccine or cure, which kills 1 in 10 people who contract it and causes long-term neurological problems in half of reported cases.
The Journal of Allergy and Clinical Immunology: In Practice (Ailsworth SM., et al.) 10.31.2023, published “Alpha-gal IgE Prevalence Patterns in the United States: An Investigation of 3000 Military Recruits”. This article investigates Alpha-gal syndrome (AGS), an allergy to mammalian meat, particularly associated with bites from lone star ticks (Amblyomma americanum).
Cell Chemical Biology (Carlson, D.L., et al.) 11.01.2023 published online “Targeting Borrelia burgdorferi HtpG with a berserker molecule, a strategy for anti-microbial development.” Researchers have found that by targeting a […]
JAMA (Yang, Y., et al. )10. 24. 2023 published an original investigation “Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.” Investigators of this clinical study conducted a randomized, double-blind, placebo-controlled clinical trial of 3777 patients with acute ST-segment elevation myocardial infarction (STEMI). Patients from 124 hospitals in China presenting with STEMI between May-December 2020 were given either oral Tongxinluo or placebo within 24 hours of symptom onset. The adjunctive treatment or placebo was administered for 12 months, and positive patient outcome was observed.
LDA Doctor Referral System © Terms & Conditions and Guidelines
Save this Information for Your Records:
About LDA DOCTOR REFERRAL SYSTEM ©
Welcome to the Lyme Disease Association’s LDA Doctor Referral System ©. LDA made updates and enhancements to its prior system and has launched a new site to provide patients with information about doctors, other practitioners, testing labs, and pharmacies that are knowledgeable about chronic Lyme disease and often about many other tick-borne diseases (TBD). Many of the doctors listed are often referred to as Lyme Literate Physicians/Doctors (LLMD). Tens of thousands of patients have successfully used the prior LDA system to locate Lyme and TBD resources.
Terms & Conditions and Guidelines
Because there is a negative political climate surrounding Lyme disease, many LLMDs do not want their names posted outright on the internet. LDA has tried to balance the doctors’ wishes with patients’ need to find a doctor. This new system is a result of that compromise and therefore:
Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines, Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the LDA Doctor Referral System © contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the location entered and specaialty/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of so we can investigate.